Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

NCT02953301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycosis Fungoides
Sezary Syndrome
Lymphoma, T-Cell, Cutaneous

Interventions

DRUG: resminostat
DRUG: Placebo

Sponsor

4SC AG